Cvs Health (CVS) Enterprise Value (2009 - 2026)

Cvs Health has reported Enterprise Value for 18 years, with the latest figure at -$11.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 6.83% year-over-year to -$11.6 billion; the trailing twelve-month figure through Mar 2026 stood at -$11.6 billion (up 6.83% YoY), and the FY2025 full-year result was -$10.4 billion, up 3.63% from the prior year.
• Enterprise Value for Q1 2026 stood at -$11.6 billion, down from -$10.4 billion in the prior quarter.
• The five-year high for Enterprise Value was -$9.5 billion in Q3 2024, with the low at -$19.7 billion in Q3 2022.
• Historically, Enterprise Value has averaged -$13.6 billion across 5 years, with a median of -$12.9 billion in 2024.
• Annual changes were most pronounced in 2023 — Enterprise Value plunged 58.83% — and 2024, when it soared 40.57%.
• Cvs Health's Enterprise Value stood at -$15.4 billion in 2022, then gained by 26.86% to -$11.3 billion in 2023, then advanced by 4.05% to -$10.8 billion in 2024, then advanced by 3.63% to -$10.4 billion in 2025, then slipped by 11.42% to -$11.6 billion in 2026.
• The last three Enterprise Value figures came in at -$11.6 billion (Q1 2026), -$10.4 billion (Q4 2025), and -$11.0 billion (Q3 2025), per Business Quant data.